The Scientist Staff | Jan 22, 1989 | 2 min read
"One of the big problems we had in venture capitalism was that in order to check an idea, you had to start a company," says David Rammler. But no more. Rammler, an organic chemist-turned-financier who has been involved with eight startups and is a former director of research in the Institute for Molecular Biology at Syntex Corp., solved that problem a year ago by forming a venture capital firm that employs more scientists than MBAs--and which thoroughly tests ideas from potential scientist/en